医学临床研究
醫學臨床研究
의학림상연구
JOURNAL OF CLINICAL RESEARCH
2014年
5期
852-855
,共4页
张育民%李庆宽%全勇%史桂霞%肖晓霞%李峰%陈科新%梁薇芬
張育民%李慶寬%全勇%史桂霞%肖曉霞%李峰%陳科新%樑薇芬
장육민%리경관%전용%사계하%초효하%리봉%진과신%량미분
冠心病/血液%半乳糖凝集素 3/诊断
冠心病/血液%半乳糖凝集素 3/診斷
관심병/혈액%반유당응집소 3/진단
Coronary Disease/BL%Galectin 3/DI
【目的】观察冠心病及其不同分型患者血清中半乳糖凝集素-3(Gal-3)的水平,分析其与高敏 C反应蛋白(hs-CRP)、单核细胞趋化因子-1(MCP-1)的相关性,探讨 Gal-3在冠心病患者中的临床价值。【方法】收集经冠状动脉造影确诊的冠心病患者97例作为冠心病组,其中稳定性心绞痛组31例,不稳定心绞痛组35例,急性心肌梗死组31例,并收集冠脉造影正常的非冠心病患者30例作为对照组。采集入选病例一般临床资料,检测其血清 Gal-3、MCP-1及血浆 hs-CRP浓度。【结果】冠心病组血清 Gal-3水平明显高于对照组(P<0.05),不稳定心绞痛组和急性心肌梗死组血清 Gal-3水平显著高于稳定性心绞痛组(P<0.05),而急性心肌梗死组血清 Gal-3水平高于不稳定心绞痛组,但差异不具统计学意义(P >0.05);冠心病患者血清 Gal-3水平与 hs-CRP、MCP-1水平显著正相关(P <0.05)。【结论】冠心病患者血清 Gal-3水平明显增高,血清Gal-3有望成为急性冠脉综合征新的生化标志物,具有重要的临床意义。联合检测 Gal-3、hs-CRP及 MCP-1对冠心病的早期诊断、危险分层及预后具有重要临床意义。
【目的】觀察冠心病及其不同分型患者血清中半乳糖凝集素-3(Gal-3)的水平,分析其與高敏 C反應蛋白(hs-CRP)、單覈細胞趨化因子-1(MCP-1)的相關性,探討 Gal-3在冠心病患者中的臨床價值。【方法】收集經冠狀動脈造影確診的冠心病患者97例作為冠心病組,其中穩定性心絞痛組31例,不穩定心絞痛組35例,急性心肌梗死組31例,併收集冠脈造影正常的非冠心病患者30例作為對照組。採集入選病例一般臨床資料,檢測其血清 Gal-3、MCP-1及血漿 hs-CRP濃度。【結果】冠心病組血清 Gal-3水平明顯高于對照組(P<0.05),不穩定心絞痛組和急性心肌梗死組血清 Gal-3水平顯著高于穩定性心絞痛組(P<0.05),而急性心肌梗死組血清 Gal-3水平高于不穩定心絞痛組,但差異不具統計學意義(P >0.05);冠心病患者血清 Gal-3水平與 hs-CRP、MCP-1水平顯著正相關(P <0.05)。【結論】冠心病患者血清 Gal-3水平明顯增高,血清Gal-3有望成為急性冠脈綜閤徵新的生化標誌物,具有重要的臨床意義。聯閤檢測 Gal-3、hs-CRP及 MCP-1對冠心病的早期診斷、危險分層及預後具有重要臨床意義。
【목적】관찰관심병급기불동분형환자혈청중반유당응집소-3(Gal-3)적수평,분석기여고민 C반응단백(hs-CRP)、단핵세포추화인자-1(MCP-1)적상관성,탐토 Gal-3재관심병환자중적림상개치。【방법】수집경관상동맥조영학진적관심병환자97례작위관심병조,기중은정성심교통조31례,불은정심교통조35례,급성심기경사조31례,병수집관맥조영정상적비관심병환자30례작위대조조。채집입선병례일반림상자료,검측기혈청 Gal-3、MCP-1급혈장 hs-CRP농도。【결과】관심병조혈청 Gal-3수평명현고우대조조(P<0.05),불은정심교통조화급성심기경사조혈청 Gal-3수평현저고우은정성심교통조(P<0.05),이급성심기경사조혈청 Gal-3수평고우불은정심교통조,단차이불구통계학의의(P >0.05);관심병환자혈청 Gal-3수평여 hs-CRP、MCP-1수평현저정상관(P <0.05)。【결론】관심병환자혈청 Gal-3수평명현증고,혈청Gal-3유망성위급성관맥종합정신적생화표지물,구유중요적림상의의。연합검측 Gal-3、hs-CRP급 MCP-1대관심병적조기진단、위험분층급예후구유중요림상의의。
[Objective]To observe serum level of galectin-3(Gal-3)in patients with different types of coro-nary heart disease and analyze its correlation with high-sensitivity C-reactive protein(hs-CRP)and monocyte chemokine protein-1(MCP-1),and to explore clinical value of Gal-3 in patients with coronary heart disease.[Methods]Totally 97 patients with coronary heart disease confirmed by coronary angiography were collected as coronary heart disease groups including stable angina pectoris group(group SA,n=31),unstable angina pec-toris group(group UA,n=35)and acute myocardial infarction(group AMI,n=31).Other 30 non-coronary heart disease patients with normal coronary angiography were collected as control group.General clinical data of all subjects were collected.Serum levels of Gal-3,MCP-1 and plasma hs-CRP were assayed.[Results]Ser-um Gal-3 level in coronary heart disease group was obviously higher that in control group(P<0.05).Serum Gal-3 levels in UA group and AMI group were markedly higher than those in SA group(P <0.05).Serum Gal-3 level in AMI group was higher than that in UA group,but there was significant difference(P>0.05). Serum Gal-3 level in patients with coronary heart disease was positively correlated with hs-CRP and MCP-1 significantly(P<0.05).[Conclusion]Serum Gal-3 level in patients with coronary heart disease is increased obviously,and may be a new biomarker for acute coronary syndrome,and has important clinical significance. Combined detection of Gal-3,hs-CRP and MCP-1 has important clinical significance in the early diagnosis,risk stratification and prognosis of coronary heart disease.